Veracyte (VCYT)
(Delayed Data from NSDQ)
$21.67 USD
-0.32 (-1.46%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $21.67 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth A Momentum D VGM
Brokerage Reports
Veracyte, Inc. [VCYT]
Reports for Purchase
Showing records 1 - 20 ( 42 total )
Company: Veracyte, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Optimized Entry and Exit Levels for VCYT 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Transition to ILMN Multi-Platform Strategy and Strong Testing Growth Providing LT Visibility
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
2Q23 - Exceeds Estimates with Decipher Dx Driving Growth
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
1Q23 Exceeds and Percepta a LT Catalyst
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
Record Testing Volumes and Visibility Into Long-Term Growth
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Veracyte, Inc.
Industry: Medical - Instruments
Company: Veracyte, Inc.
Industry: Medical - Instruments
3Q22 - Clinical Evidence Driving Revenue Momentum
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department